对儿科药房住院计划主任和研究生培训路径前住院人员的调查
Corinne N Songer1, Deborah S Bondi2, Lauren M Oliveri3,4
1Department of Pharmacy (CNS), Ascension St. John Hospital, Detroit, MI.
概括
传统的和专注于儿科的PGY1药房住院为PGY2计划提供了类似的准备. 两种路径的居民都获得了儿科药剂师的工作,表明了可比的职业准备.
科学领域:
- 药房 教育 教育 药房 教育
- 儿科药房实践 儿科药房实践
- 住院培训 培训 住院培训
背景情况:
- 传统的PGY1课程提供广泛的培训,而以儿科为重点的PGY1课程则专注于专门的儿科知识.
- 目前没有数据可以根据PGY1计划类型对PGY2儿科药房住院的住院准备情况进行比较.
研究的目的:
- 为了确定PGY1计划类型 (传统与儿科专注) 是否会影响PGY2儿科药房住院的住院准备.
主要方法:
- 对PGY2儿科住院项目主任和最近的PGY2儿科住院人员 (2016-2020) 分发了一份调查.
- 收集的数据包括PGY1培训路径和对PGY2儿科住院的准备感,评估一般和儿科特定技能.
主要成果:
- RPDs认为专注于儿科的PGY1居民在儿科疾病知识方面更准备好.
- 与传统的PGY1居民相比,专注于儿科的PGY1居民在儿科基线知识和紧急管理方面报告了更高的准备.
- 在患者护理准备,临床研究或整体工作过渡方面没有发现显著差异.
结论:
- 虽然以儿科为重点的PGY1计划增强了特定的儿科知识,但两种PGY1类型都为PGY2儿科住院和随后的职业生涯做好了类似的准备.
- 对于儿科药房实践的整体准备是可比的,无论选择PGY1住院途径.
相关概念视频
Analysis of Population Pharmacokinetic Data
266
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
266
Pharmacovigilance
838
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
838
Routes of Drug Administration: Parenteral
2.0K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
2.0K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Drug Administration and Therapy Phases: Overview
475
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
475
Pharmacokinetic Models: Overview
706
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
706


